Navigation Links
E-cigarettes and mental health
Date:5/12/2014

Researchers at University of California, San Diego School of Medicine report that people living with depression, anxiety or other mental health conditions are twice as likely to have tried e-cigarettes and three times as likely to be current users of the controversial battery-powered nicotine-delivery devices, as people without mental health disorders.

They are also more susceptible to trying e-cigarettes in the future in the belief that doing so will help them quit, the scientists said. The FDA has not approved e-cigarettes as a smoking cessation aid.

The study will be published in the May 13 online issue of Tobacco Control.

"The faces of smokers in America in the 1960s were the 'Mad Men' in business suits," said lead author Sharon Cummins, PhD, assistant professor in the Department of Family and Preventive Medicine. "They were fashionable and had disposable income. Those with a smoking habit today are poorer, have less education, and, as this study shows, have higher rates of mental health conditions."

By some estimates, people with psychiatric disorders consume approximately 30 to 50 percent of all cigarettes sold annually in the U.S.

"Since the safety of e-cigarettes is still unknown, their use by nonsmokers could put them at risk," Cummins said. Another concern is that the widespread use of e-cigarettes could reverse the social norms that have made smoking largely socially unacceptable.

The study shows that smokers, regardless of their mental health condition, are the primary consumers of the nicotine delivery technology. People with mental health disorders also appear to be using e-cigarettes for the same reasons as other smokers to reduce potential harm to their health and to help them break the habit.

"So far, nonsmokers with mental health disorders are not picking up e-cigarettes as a gateway to smoking," Cummins said.

The study is based on a survey of Americans' smoking history, efforts to quit and their use and perceptions about e-cigarettes. People were also asked whether they had ever been diagnosed with an anxiety disorder, depression or other mental health condition.

Among the 10,041 people who responded to the survey, 27.8 percent of current smokers had self-reported mental health conditions, compared with 13.4 percent of non-smokers; 14.8 percent of individuals with mental health conditions had tried e-cigarettes, and 3.1 percent were currently using them, compared with 6.6 percent and 1.1 percent without mental health conditions, respectively.

In addition, 60.5 percent of smokers with mental health conditions indicated that they were somewhat likely or very likely to try e-cigarettes in the future, compared with 45.3 percent of smokers without mental health conditions.

"People with mental health conditions have largely been forgotten in the war on smoking," Cummins said. "But because they are high consumers of cigarettes, they have the most to gain or lose from the e-cigarette phenomenon. Which way it goes will depend on what product regulations are put into effect and whether e-cigarettes ultimately prove to be useful in helping smokers quit."


'/>"/>

Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert

Related medicine news :

1. Young parents who use e-cigarettes believe devices are safer for those around them
2. E-cigarettes: Gateway to nicotine addiction for US teens, says UCSF study
3. 44 percent of adults worry e-cigarettes will encourage kids to start smoking tobacco
4. First trial to compare e-cigarettes with nicotine patches
5. UIC researchers to study how young adults use e-cigarettes, snus
6. Experts warn that e-cigarettes can damage the lungs
7. Experimental antibody shows early promise for treatment of childhood tumor
8. Genetic, environmental influences equally important risk for autism spectrum disorder
9. Environmental factors as important as genes in understanding autism
10. Discrimination associated with mental health woes in black teens
11. Experimental drug prolongs life span in mice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance ... greater Dallas, Miami, and Raleigh regions, is organizing an extended charity drive to ... and deadly chromosome abnormality. , After struggling since birth with several health challenges, ...
(Date:10/13/2017)... ... 13, 2017 , ... The American Board of Family Medicine's (ABFM) Board of ... Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will serve ... Puffer’s retirement at the end of 2018. Upon assuming the role of President and ...
(Date:10/13/2017)... ... 2017 , ... Lori R. Somekh, founder of the Law Office of ... elder law and special needs planning attorneys. “Membership in ElderCounsel helps our office remain ... to network with elder law attorneys nationwide,” said Somekh. , ElderCounsel ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Ellevate Network, ... in business to advocate for action towards gender equality at their inaugural Summit in ... around the globe, and reached a social audience of over 3 million. To watch ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader ... been awarded a contract by the Center for Medicare and Medicaid Services (CMS). ... the enterprise use of Agile methodologies in a consistent and high value manner ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host ... webcast on Friday, November 3, 2017, beginning at 7:00 ... approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... performance and guidance for 2018, Hill-Rom executives will also ... performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: ... data solutions, today announced that its MyDario product is expected to appear ... listings for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, The ... ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: